Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 26 September

Grady Wulff
September 26, 2022

Morning Bell 23 September

Sophia Mavridis
September 23, 2022

Closing Bell 21 September

Grady Wulff
September 21, 2022

Morning Bell 21 September

Grady Wulff
September 21, 2022

Closing Bell 20 September

Grady Wulff
September 20, 2022

Morning Bell 20 September

Paulina Peters
September 20, 2022

Closing Bell 19 September

Grady Wulff
September 19, 2022

Morning Bell 19 September

Grady Wulff
September 19, 2022

Weekly Wrap 16 September

Grady Wulff
September 16, 2022

Morning Bell 16 September

Sophia Mavridis
September 16, 2022

Morning Bell 15 September

Sophia Mavridis
September 15, 2022

Closing Bell 14 September

Grady Wulff
September 14, 2022